Try our business solution for free!

Total R&D costs of select cancer drugs 2017

Total R&D costs for selected cancer drugs on the market as of 2017

Exclusive Premium statistic

You need a Statista Account for unlimited access.

  • Full access to 1m statistics
  • Incl. source references
  • Available to download in PNG, PDF, XLS format
Statista Accounts

Access to this and all other statistics on 80,000 topics from

$468 USD / Year
$828 USD / Year

Show detailed source information?
Register for free
Already a member?
Log in

Use Ask Statista Research Service

Release date

November 2017


United States

Survey time period

as of November 2017

Supplementary notes

This statistic includes only pharmaceutical companies with a single oncologic drug approved by the Food and Drug Administration (FDA). Values are inflation adjusted for 2017 U.S. dollars.
* Alexion later had two drug approvals in the last quarter of 2015; these drugs are not included in this statistic.
** Compound acquired by the company on this date.

Citation formats
Statista Accounts: Access All Statistics. Starting from $468 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$69 USD $39 USD / Month *
in the first 12 months
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Oncology "

Statistics on Oncology

Cancer facts


Oncology market




Cancer drugs


Research and development




Treatment types


Physicians and patients


Further related statistics

Statista Accounts: Access All Statistics. Starting from $468 USD / Year
Learn more about how Statista can support your business.